Unum is a Cambridge, MA-based company developing novel cellular therapies to treat a wide range of cancers. Our investigational therapies work as combination products, pairing a tumor-specific antibody together with genetically modified T cells isolated from the patient. Unlike other approaches, our investigational therapies are not restricted to a particular target and may be used in many different cancer types. We are currently clinically testing our product candidates in patients with lymphoma and multiple myeloma and are expanding our efforts to encompass several additional cancer types in the near future.
Copyright West LLC. Minimum 15 minutes delayed.
Mar 21, 2019
Mar 05, 2019
Jan 04, 2019
Mar 12, 2019 at 11:20 AM EDT
Nov 19, 2018 at 8:30 AM EST
Nov 12, 2018 at 4:30 PM EST
More information is coming soon.